Canopy Growth

Canopy Growth

Canopy Growth Corporation is a world-leading diversified cannabis company. We operate a collection of diverse brands and curated strain variety, supported millions of square feet of indoor greenhouse production capacity, partnered with some of the leading names in the sector.
Summary
Fiscal year-end
March
Headquarters
Smith Falls, ON
Licensed Facilities
13
Number of Patients
~74,000
Financials (Pro Forma 6/30)
Cash on hand
$429 million
Fixed investment
$661 million
Shareholders’ equity
$2.98 billion
Revenues – last quarter
$25.3 million
Adj. gross margin
28.2%
EPS
$-1.52
Capital Structure
Capital structure
11/13/18
Last financing
$5 billion Constellation Investment
Basic shares
328.2 million
Warrants
159.6 million
Options
22.2 million
Diluted shares
522.4 million

Canopy Growth News

10 hours ago

3 Crazy Facts About Canopy Growth's Largest Acquisition in Marijuana History

Canopy's $3.4 billion purchase of Acreage Holdings is unlike anything Wall Street or investors have ever seen.

1 day ago

Harvest Health CEO Steve White Talks Cannabis Consolidation, Says Canopy-Acreage Tie-Up 'Fantastic'

Harvest Health & Recreation, Inc. (OTC: HRVSF ) CEO Steve White joined Yahoo's Jeff Lagerquist onstage Thursday at the Benzinga Cannabis Capital Conference to discuss consolidation in the marijuana industry. ...

19 Apr

Marijuana Stocks Take the Long-Term View. But Expect ‘Teething’ Problems.

Investor interest in marijuana stocks led Jefferies to hold its first cannabis conference, featuring 30 companies and 260 investors. Here are a few things that marijuana companies are thinking about for...

19 Apr

Canopy Growth: U.S. Future Might Not Happen

After dozens of acquisitions in the last few years, Canopy Growth ( CGC ) finally made a big move into the U.S. market. The proposed deal has a one big catch that could leave the Canadian cannabis...

19 Apr

High Expectations For A Budding Industry (Video)

The cannabis sector has seen some recent action after somewhat of a drought. 2017 was a breakout year for many new entrants into the medicinal marijuana realm, and many acted like crypto currencies did...

19 Apr

Canopy Growth Makes A Fascinating Bet On U.S. Cannabis

In the cannabis industry, innovation is key to growth, and a big part of innovation is acquiring firms that complement the parent company in question. In its latest move, the management team at Canopy...

18 Apr

Hot pot deal: Canopy Growth buys Acreage Holdings for $3.4 billion

Marijuana M&A heats up, as Canopy buys Acreage. Bruce Linton, Canopy CEO, and Kevin Murphy, Acrage CEO, discuss with CNBC's Melissa Lee and the Fast Money traders, Tim Seymour, Brian Kelly, Steve Grasso...

18 Apr

Welcome To America: Canopy Growth Purchases Acreage Holdings

Summary Canopy Growth (CGC) has announced a deal that gives the company the right to purchase Acreage Holdings ( ACRGF ) when legally permissible. Companies on a major stock exchange can't operate...

18 Apr

How to Know When to Buy Marijuana Stocks

A company that jumps to a major stock exchange is the "rocket ship" event of marijuana stocks. It can send shares soaring to a whole new level -- into the stratosphere.This is what my research...

18 Apr

5 Must-See Stock Charts for Monday: CGC, PINS, NVTA, UNP, BX

It's the same action that we've had for much of this week. Stocks press lower near the open only to recover by lunch and push higher in the afternoon. The gains aren't remarkable, but the bulls'...

Load more

About Canopy Growth

Our vision is to be the number one cannabis company in the world. From product and process innovation to market execution and everything in between, we are driven by a passion for leadership, a commitment to drive the industry forward, and above all else, providing medical and recreational cannabis consumers the best possible experience.

Our Story
In April 2014, Canopy Growth became the first cannabis company in North America to be publicly traded. We followed that with being the first to complete a “bought deal”, to diversify our platform to include both greenhouse and indoor growing, to acquire a major competitor and to be listed on the Toronto Stock Exchange. Continuing those firsts, we remain the only cannabis company to be a member of a major global stock market index, in this case the S&P/TSX Composite index.

Away from the markets, Tweed, a Canopy Growth subsidiary, was the first to introduce the now standard concept of Compassionate Pricing to make medical cannabis affordable for patients, and we remain proud to continue supporting a patient’s right to grow at home by selling the widest variety of seeds in the legal Canadian sector. Our commitment to education has and always will be unwavering, as one of the first Canadian cannabis companies to offer Mainpro-M1 accredited continuing medical education programs to Canadian physicians, and to launch in-person assistance through our Tweed Main Street locations. Tweed was also the first Canadian producer to be approved to export dried cannabis to Germany, and our wholly-owned German subsidiary continues to offer an ever-increasing variety of products for sale through German pharmacies. Canopy Growth was the first to strike a strategic relationship with a Fortune 500 beverage alcohol supplier to bring exciting new products to market, and to enter into ground-breaking supply agreements to sell adult-use cannabis to provincial governments across the country. Most recently, in May 2018, it was the first cannabis-producing company to be listed on the New York Stock Exchange.

From our cutting edge research at Canopy Health Innovations, to our hemp operations and financing services through Canopy Rivers Corporation, we are proud of our accomplishments, and are always looking for the next first.

Our Story

In April 2014, Canopy Growth became the first cannabis company in North America to be publicly traded. We followed that with being the first to complete a “bought deal”, to diversify our platform to include both greenhouse and indoor growing, to acquire a major competitor and to be listed on the Toronto Stock Exchange. Continuing those firsts, we remain the only cannabis company to be a member of a major global stock market index, in this case the S&P/TSX Composite index.

Away from the markets, Tweed, a Canopy Growth subsidiary, was the first to introduce the now standard concept of Compassionate Pricing to make medical cannabis affordable for patients, and we remain proud to continue supporting a patient’s right to grow at home by selling the widest variety of seeds in the legal Canadian sector. Our commitment to education has and always will be unwavering, as one of the first Canadian cannabis companies to offer Mainpro-M1 accredited continuing medical education programs to Canadian physicians, and to launch in-person assistance through our Tweed Main Street locations. Tweed was also the first Canadian producer to be approved to export dried cannabis to Germany, and our wholly-owned German subsidiary continues to offer an ever-increasing variety of products for sale through German pharmacies. Canopy Growth was the first to strike a strategic relationship with a Fortune 500 beverage alcohol supplier to bring exciting new products to market, and to enter into ground-breaking supply agreements to sell adult-use cannabis to provincial governments across the country. Most recently, in May 2018, it was the first cannabis-producing company to be listed on the New York Stock Exchange.

From our cutting edge research at Canopy Health Innovations, to our hemp operations and financing services through Canopy Rivers Corporation, we are proud of our accomplishments, and are always looking for the next first.

Here’s to Future Growth.

Corporate Governance

Canopy Growth Corporation’s ISS Governance QualityScore as of January 28, 2019 is 10. The pillar scores are Audit: 10; Board: 10; Shareholder Rights: 6; Compensation: 10.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Features Canopy Growth

Canadian Operations

  • A leading publicly traded producer in terms of revenue, grams shipped and registered medical patients
  • 4.3 million-square-foot licensed footprint with plans for expansion to 5.6 million square feet
  • Multiple production facilities in provinces including Alberta, British Columbia, Saskatchewan, Ontario, Québec, New Brunswick, and Newfoundland
  • Cannabis supply agreements in Alberta, Quebec, Newfoundland & Labrador, Manitoba, British Columbia, New Brunswick, Prince Edward Island, Northwest Territory, Nunavut, and the Yukon
  • First publicly-traded LP (April 2014) and first to attain listing on the Toronto Stock Exchange (August 2016) and the New York Stock Exchange (May 2018)
  • $5 billion CAD investment from Constellation Brands
  • Brick-and-mortar presence with Tweed brand and Tokyo Smoke stores
  • Curated CraftGrow line from Tweed
  • Strategic relationship with operating platform Canopy Rivers and wholly-owned biopharmaceutical subsidiary Canopy Health Innovations
  • Investment in hemp research through Green Hemp Industrie and ebbu acquisitions

Global Operations 

  • Operating across five continents
  • International subsidiaries and partnerships in Germany, Chile, Columbia, Denmark, Jamaica, Lesotho, Australia, Brazil, Czech Republic, Spain, Poland, and the UK
  • Export agreements in Australia, Brazil, Czech Republic, Denmark, Germany, and Spain
  • Strong international presence through Spectrum including Spektrum in Germany, Spectrum Demark, Spectrum Czech, Spectrum Australia, Spectrum Lesotho, Spectrum Cannabis Colombia, and Spectrum Chile
    Canopy LATAM, based in Brazil, to advance medical cannabis under the Spectrum brand
  • 49% ownership of Jamaican company Tweed JA
  • New York hemp license and plans to establish commercial operations in the U.S.

Financials Canopy Growth

  • 06/15/18 – Size: $600.0mm – Security: 4.25% Convertible Notes – Price: $48.18
  • 01/17/18 – Size: $200.0mm – Security: 5.8mm common shares – Price: $34.60
  • 11/02/17 – Size: $245mm – Security: 18.9mm common shares and 18.9mm warrants at $12.98 (Constellation Brands strategic investment) – Price: $12.98
  • 07/26/17 – Size: $25mm – Security: 3.1mm common shares via private placement – Price: $8.05
  • 03/22/17 – Size: $24.25mm – Security: 2.5mm common shares via private placement – Price: $9.70
  • 12/5/16 – Size: $60.0mm – Security: 5.662mm common shares – Price: $10.60
  • 8/8/16 – Size: $34.5mm – Security: 9.453mm common shares – Price: $3.65
  • 3/22/16 – Size: $11.5mm – Security: 5mm common shares – Price: $2.30
  • 10/23/15 – Size: $14.4mm – Security: 7.01mm common shares – Price $2.05 

Participation in events

Jobs

Position
City
Type
Salary
Posted
CITY:
Yorkton Saskatchewan, Canada
TYPE:
Full-Time
SALARY:
DOE
POSTED:
27 Mar 2019
CITY:
Toronto Ontario, Canada
TYPE:
Full-Time
SALARY:
DOE
POSTED:
26 Feb 2019
$ 44.56
0.04%
Open:
46.70
High:
47.71
Low:
44.16
Share volume:
759.211 K
Total value:
35.195 M
Market cap:
15.335 B
Symbol:
CGC